SERES THERAPEUTICS INC
MCRBNASDAQ🏆 #4619 by market capEarnings Nov 4US Equity
$3.48▼ $0.04 (−1.14%)
🌙 After hours$3.43▼ 1.44%Regular close · extended-hours price shownTrack MCRB
Get earnings, price moves & breaking news on Telegram
24h▼ 1.1%
7d▼ 8.9%
14d▼ 17.9%
30d▼ 29.4%
ytd▼ 76.5%
1y▼ 82.0%
🏦Market Cap
$34M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
82.6%
High
💵FCF Margin
-2724.1%
Thin
⚖️P/S Ratio
17.6x
Expensive
Otter Score
80
Good
SERES THERAPEUTICS INC
MCRBAnalyst Ratings
Price
$3.48
Total
18
Raised
1
Lowered
5
Avg PT
$12.00
H / L
$12 / $12
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Canaccord Genuity | Reiterated | Buy | 2026-03-13 | — | — |
Chardan Capital | Downgraded | Buy → Neutral | 2025-05-08 | $1.25 | −64.10% |
Goldman Sachs | Reiterated | Sell | 2025-03-14 | — | — |
JP Morgan | Downgraded | Neutral → Underweight | 2024-10-24 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2024-06-07 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2023-03-08 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-09-07 | — | — |
JMP Securities | Reiterated | Market Perform → Perform | 2020-12-23 | — | — |
Jefferies | Upgraded | Hold → Buy | 2020-08-11 | — | — |
Bank of America | Downgraded | Neutral → Underperform | 2018-08-03 | — | — |
B of A Securities | Downgraded | Neutral → Underperform | 2018-08-03 | — | — |
Seaport Global | Reiterated | Buy | 2017-10-06 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2016-12-16 | — | — |
Cowen & Co. | Reiterated | Outperform | 2016-06-06 | — | — |
FBR Capital | Reiterated | Outperform | 2016-03-30 | — | — |
Guggenheim | Reiterated | Buy | 2016-03-03 | — | — |
H.C. Wainwright | Reiterated | Buy | 2016-01-25 | $12.00 | +244.80% |
Leerink Swann | Reiterated | Outperform | 2015-07-21 | — | — |
Institution
Canaccord Genuity
Reiterated · Buy · 2026-03-13
—
—
Chardan Capital
Downgraded · Buy → Neutral · 2025-05-08
$1.25
−64.10%
Goldman Sachs
Reiterated · Sell · 2025-03-14
—
—
JP Morgan
Downgraded · Neutral → Underweight · 2024-10-24
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2024-06-07
—
—
HC Wainwright & Co.
Reiterated · Buy · 2023-03-08
—
—
Piper Sandler
Reiterated · Overweight · 2022-09-07
—
—
JMP Securities
Reiterated · Market Perform → Perform · 2020-12-23
—
—
Jefferies
Upgraded · Hold → Buy · 2020-08-11
—
—
Bank of America
Downgraded · Neutral → Underperform · 2018-08-03
—
—
B of A Securities
Downgraded · Neutral → Underperform · 2018-08-03
—
—
Seaport Global
Reiterated · Buy · 2017-10-06
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2016-12-16
—
—
Cowen & Co.
Reiterated · Outperform · 2016-06-06
—
—
FBR Capital
Reiterated · Outperform · 2016-03-30
—
—
Guggenheim
Reiterated · Buy · 2016-03-03
—
—
H.C. Wainwright
Reiterated · Buy · 2016-01-25
$12.00
+244.80%
Leerink Swann
Reiterated · Outperform · 2015-07-21
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space